These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17185703)

  • 1. Scrooge and intellectual property rights.
    Stiglitz JE
    BMJ; 2006 Dec; 333(7582):1279-80. PubMed ID: 17185703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intellectual property rights and drug prices.
    Lexchin J
    Lancet; 1998 Aug; 352(9127):582. PubMed ID: 9716098
    [No Abstract]   [Full Text] [Related]  

  • 3. Extensions of intellectual property rights and delayed adoption of generic drugs: effects on medicaid spending.
    Kesselheim AS; Fischer MA; Avorn J
    Health Aff (Millwood); 2006; 25(6):1637-47. PubMed ID: 17102189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction between intellectual property and drug regulatory systems: global perspectives.
    Madden EA
    IDrugs; 2007 Feb; 10(2):116-20. PubMed ID: 17285464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharma Dynamics: targeting safe, effective and affordable medication for South Africa and neighbouring countries.
    Cardiovasc J Afr; 2009; 20(1):85. PubMed ID: 19287824
    [No Abstract]   [Full Text] [Related]  

  • 6. Academics should use their intellectual property to produce cheap drugs for poor countries.
    Watts G
    BMJ; 2007 May; 334(7603):1079. PubMed ID: 17525425
    [No Abstract]   [Full Text] [Related]  

  • 7. International Generic Pharmaceutical Alliance - 12th Annual Conference. Part 2.
    Kuhrt K
    IDrugs; 2009 Dec; 12(12):765-9. PubMed ID: 19943218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health and intellectual property rights.
    Correa CM
    Bull World Health Organ; 2001; 79(5):381. PubMed ID: 11417031
    [No Abstract]   [Full Text] [Related]  

  • 9. Fine print TRIPS up multinational and Indian companies.
    Frantz S
    Nat Rev Drug Discov; 2005 Feb; 4(2):94-5. PubMed ID: 15759327
    [No Abstract]   [Full Text] [Related]  

  • 10. Reprivatizing pharmaceutical supplies in Africa.
    Turshen M
    J Public Health Policy; 2001; 22(2):198-225. PubMed ID: 11469153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intellectual property rights are becoming less flexible, says Oxfam.
    Kmietowicz Z
    BMJ; 2002 Sep; 325(7365):614. PubMed ID: 12242164
    [No Abstract]   [Full Text] [Related]  

  • 12. The GO License: only part of the solution.
    Batson A; Milstien JB
    Health Aff (Millwood); 2008; 27(1):140-2. PubMed ID: 18180489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. World Trade Organization still threatens supply of affordable AIDS drugs.
    Hagmann M
    Bull World Health Organ; 2002; 80(9):762-3. PubMed ID: 12378300
    [No Abstract]   [Full Text] [Related]  

  • 14. A trade agreement's impact on access to generic drugs.
    Shaffer ER; Brenner JE
    Health Aff (Millwood); 2009; 28(5):w957-68. PubMed ID: 19706626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intellectual property rights, compulsory licensing and the TRIPS agreement: some ethical issues.
    Schuklenk U
    Monash Bioeth Rev; 2003 Apr; 22(2):63-8. PubMed ID: 15069958
    [No Abstract]   [Full Text] [Related]  

  • 16. Health priorities gain patent reprieve for developing countries.
    Cherry M
    Nature; 2001 Nov; 414(6862):385. PubMed ID: 11719767
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinton brokers deal to lower price of antiretrovirals.
    Abimbola S
    BMJ; 2007 May; 334(7602):1026. PubMed ID: 17510129
    [No Abstract]   [Full Text] [Related]  

  • 18. Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries.
    Spectar JM
    Houst J Int Law; 2002; 24(2):227-78. PubMed ID: 16189914
    [No Abstract]   [Full Text] [Related]  

  • 19. Canada's plan to sell generic drugs to developing countries is threatened.
    Spurgeon D
    BMJ; 2004 Mar; 328(7442):728. PubMed ID: 15044278
    [No Abstract]   [Full Text] [Related]  

  • 20. The Health Impact Fund.
    Light DW
    Lancet; 2010 Mar; 375(9718):893. PubMed ID: 20226984
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.